BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  XNK Therapeutics appoints Hugo Petit as Chief Financial Officer

  XNK Therapeutics announced the appointment of Hugo Petit as Chief Financial Officer and member of the company’s leadership team.

  June 7, 2023

   · 

  2 min read
• Business

  MRM Health Appoints Katja Conrath as Chief Scientific Officer

  MRM Health - a clinical-stage biopharmaceutical company focused on developing innovative microbiome-based biotherapeutics based on its proprietary and unique CORAL® platform technology - announced that it appointed Katja Conrath, PhD, as Chief Scientific Officer.

  June 7, 2023

   · 

  4 min read
• Drug Development

  Curasight A/S reports positive preclinical results with uTREAT® in aggressive brain cancer (glioblastoma)

  Curasight A/S is pleased to announce preclinical data demonstrating the effectiveness of uTREAT® in treating aggressive brain cancer.

  June 7, 2023

   · 

  2 min read
• D&A Pharma: New confirmation for sodium oxybate in the treatment of alcohol dependence: a university thesis provides new evidence and explains its efficacy in maintaining abstinence

  While several effective treatments are currently available for the treatment of alcohol withdrawal syndrome, there is an unmet medical need in the abstinence maintenance phase.

  June 7, 2023

   · 

  3 min read
• Dizal Leads China’s Biotech Innovation by Showcasing Strength of its Oncology Pipeline at 2023 ASCO

  Dizal presented compelling data of its robust oncology portfolio at the 2023 American Society of Clinical Oncology Annual Meeting taking place June 2-6, 2023, in Chicago.

  June 7, 2023

   · 

  12 min read
• Genetown

  Hopewell Therapeutics Announces $25 Million Seed Financing to Advance Next Generation Lipid Nanoparticles for Targeted Delivery of Genomic Medicines

  Hopewell Therapeutics, a biotechnology company with a differentiated lipid nanoparticle platform harnessing unique ionizable lipid chemistry, announced a Seed Financing of up to $25 million to support its operations and growth.

  June 7, 2023

   · 

  6 min read
• BioForest

  AbTherx Announces License Agreement with Gilead

  AbTherx, Inc., a privately held biotech company focused on accelerating the discovery and development of antibody therapeutics, announced a license agreement with Gilead Sciences, Inc.

  June 7, 2023

   · 

  2 min read
• Drug Development

  FibroGen Announces Topline Results from LELANTOS-1 Phase 3 Clinical Study of Pamrevlumab in Non-Ambulatory Patients with Duchenne Muscular Dystrophy

  FibroGen, Inc. announced topline data from the Phase 3 LELANTOS-1 placebo-controlled trial of pamrevlumab for the treatment of non-ambulatory patients with Duchenne Muscular Dystrophy on background corticosteroids.

  June 7, 2023

   · 

  6 min read
• Biotech Bay

  WILLOW BIOSCIENCES TO PRESENT AT THE EMERGING GROWTH CONFERENCE ON JUNE 14

  Willow Biosciences Inc. announces that it has been invited to present at the Emerging Growth Conference on June 14.

  June 7, 2023

   · 

  2 min read
• Genetown

  Akili Releases EndeavorOTCTM Video Game Treatment to Improve Attention in Adults with ADHD

  Akili Releases EndeavorOTC TM Video Game Treatment to Improve Attention in Adults with ADHD.

  June 7, 2023

   · 

  10 min read